Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index

BackgroundWe evaluated the clinical characteristics of insulin resistance and β-cell dysfunction in newly diagnosed, drug-naive people with type 2 diabetes by analyzing nationwide cross-sectional data.MethodsWe collected the clinical data of 912 participants with newly diagnosed diabetes from 83 pri...

Full description

Bibliographic Details
Main Authors: Kyoung Hwa Ha, Cheol Young Park, In Kyung Jeong, Hyun Jin Kim, Sang-Yong Kim, Won Jun Kim, Ji Sung Yoon, In Joo Kim, Dae Jung Kim, Sungrae Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2018-02-01
Series:Diabetes & Metabolism Journal
Subjects:
Online Access:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-137.pdf
id doaj-44e3236d15b2460c9b6b302fc0a25be7
record_format Article
spelling doaj-44e3236d15b2460c9b6b302fc0a25be72020-11-25T00:32:44ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872018-02-0142213714610.4093/dmj.2018.42.2.137Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass IndexKyoung Hwa Ha0Cheol Young Park1In Kyung Jeong2Hyun Jin Kim3Sang-Yong Kim4Won Jun Kim5Ji Sung Yoon6In Joo Kim7Dae Jung Kim8Sungrae Kim9Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University College of Medicine, Gwangju, Korea.Department of Endocrinology and Metabolism, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.Department of Endocrinology and Metabolism, Yeungnam University College of Medicine, Daegu, Korea.Department of Endocrinology and Metabolism, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.BackgroundWe evaluated the clinical characteristics of insulin resistance and β-cell dysfunction in newly diagnosed, drug-naive people with type 2 diabetes by analyzing nationwide cross-sectional data.MethodsWe collected the clinical data of 912 participants with newly diagnosed diabetes from 83 primary care clinics and hospitals nationwide from 2015 to 2016. The presence of insulin resistance and β-cell dysfunction was defined as a homeostatic model assessment of insulin resistance (HOMA-IR) value ≥2.5 and fasting C-peptide levels <1.70 ng/mL, respectively.ResultsA total of 75.1% and 22.6% of participants had insulin resistance and β-cell dysfunction, respectively. The proportion of participants with insulin resistance but no β-cell dysfunction increased, and the proportion of participants with β-cell dysfunction but no insulin resistance decreased as body mass index (BMI) increased. People diagnosed with diabetes before 40 years of age had significantly higher HOMA-IR and BMI than those diagnosed over 65 years of age (HOMA-IR, 5.0 vs. 3.0; BMI, 28.7 kg/m2 vs. 25.1 kg/m2). However, the β-cell function indices were lower in people diagnosed before 40 years of age than in those diagnosed after 65 years of age (homeostatic model assessment of β-cell function, 39.3 vs. 64.9; insulinogenic index, 10.3 vs. 18.7; disposition index, 0.15 vs. 0.25).ConclusionWe observed that the main pathogenic mechanism of type 2 diabetes is insulin resistance in participants with newly diagnosed type 2 diabetes. In addition, young adults with diabetes are more likely to have higher insulin resistance with obesity and have higher insulin secretory defect with severe hyperglycemia in the early period of diabetes than older populations.https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-137.pdfDiabetes mellitus, type 2Insulin resistanceInsulin secretion
collection DOAJ
language English
format Article
sources DOAJ
author Kyoung Hwa Ha
Cheol Young Park
In Kyung Jeong
Hyun Jin Kim
Sang-Yong Kim
Won Jun Kim
Ji Sung Yoon
In Joo Kim
Dae Jung Kim
Sungrae Kim
spellingShingle Kyoung Hwa Ha
Cheol Young Park
In Kyung Jeong
Hyun Jin Kim
Sang-Yong Kim
Won Jun Kim
Ji Sung Yoon
In Joo Kim
Dae Jung Kim
Sungrae Kim
Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
Diabetes & Metabolism Journal
Diabetes mellitus, type 2
Insulin resistance
Insulin secretion
author_facet Kyoung Hwa Ha
Cheol Young Park
In Kyung Jeong
Hyun Jin Kim
Sang-Yong Kim
Won Jun Kim
Ji Sung Yoon
In Joo Kim
Dae Jung Kim
Sungrae Kim
author_sort Kyoung Hwa Ha
title Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
title_short Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
title_full Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
title_fullStr Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
title_full_unstemmed Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
title_sort clinical characteristics of people with newly diagnosed type 2 diabetes between 2015 and 2016: difference by age and body mass index
publisher Korean Diabetes Association
series Diabetes & Metabolism Journal
issn 2233-6079
2233-6087
publishDate 2018-02-01
description BackgroundWe evaluated the clinical characteristics of insulin resistance and β-cell dysfunction in newly diagnosed, drug-naive people with type 2 diabetes by analyzing nationwide cross-sectional data.MethodsWe collected the clinical data of 912 participants with newly diagnosed diabetes from 83 primary care clinics and hospitals nationwide from 2015 to 2016. The presence of insulin resistance and β-cell dysfunction was defined as a homeostatic model assessment of insulin resistance (HOMA-IR) value ≥2.5 and fasting C-peptide levels <1.70 ng/mL, respectively.ResultsA total of 75.1% and 22.6% of participants had insulin resistance and β-cell dysfunction, respectively. The proportion of participants with insulin resistance but no β-cell dysfunction increased, and the proportion of participants with β-cell dysfunction but no insulin resistance decreased as body mass index (BMI) increased. People diagnosed with diabetes before 40 years of age had significantly higher HOMA-IR and BMI than those diagnosed over 65 years of age (HOMA-IR, 5.0 vs. 3.0; BMI, 28.7 kg/m2 vs. 25.1 kg/m2). However, the β-cell function indices were lower in people diagnosed before 40 years of age than in those diagnosed after 65 years of age (homeostatic model assessment of β-cell function, 39.3 vs. 64.9; insulinogenic index, 10.3 vs. 18.7; disposition index, 0.15 vs. 0.25).ConclusionWe observed that the main pathogenic mechanism of type 2 diabetes is insulin resistance in participants with newly diagnosed type 2 diabetes. In addition, young adults with diabetes are more likely to have higher insulin resistance with obesity and have higher insulin secretory defect with severe hyperglycemia in the early period of diabetes than older populations.
topic Diabetes mellitus, type 2
Insulin resistance
Insulin secretion
url https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-137.pdf
work_keys_str_mv AT kyounghwaha clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT cheolyoungpark clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT inkyungjeong clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT hyunjinkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT sangyongkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT wonjunkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT jisungyoon clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT injookim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT daejungkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
AT sungraekim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex
_version_ 1725319353721683968